Ne. Spanakis et al., Aberrant p16 expression is correlated with hemizygous deletions at the 9p21-22 chromosome region in non-small cell lung carcinomas, ANTICANC R, 19(3A), 1999, pp. 1893-1899
The p16 protein is encoded by the CDKN2 gene, and functions as an inhibitor
of cyclin-dependent kinase 4 anal 6 (CDK4/6). Phosphorylation of the retin
oblastoma protein pRb) by CDK4/6 represents a vital step in cell cycle prog
ression. Alterations of p16(INK4A) are frequent events in human malignancie
s. In non-small cell lung carcinoma (NSCLC) the data concerning the mechani
sms of p16(INK4A) inactivation suggest that point mutations and aberrant me
thylation of its promoter can only account for a proportion of the cases wi
th abnormal p16 immunoexpression. The role of deletions in this procedure i
s not yet clarified. In order to gain more insight into the role of deletio
ns in p16(INK4A) deregulated expression, we investigated the state of the c
hromosomal region 9p21-22 in a series of 57 NSCLCs, by performing a detaile
d mapping analysis, using a tight cluster of highly polymorphic microsatell
ite markers, and correlating the findings with p16 immunostaining. Abnormal
p16 expression was observed in 46% of the NSCLCs examined. No relationship
was observed between p16 abnormal staining and various clinicopathological
parameters. Abnormal p16 protein staining was strongly associated with hem
izygous deletions at the IFNA and D9S171 microsatellite loci, which demarca
te the region encoding the p16(INK4A) gene (P=0.002). These findings sugges
t that deregulated expression of p16 is involved in the multistage process
of NSCL carcinogenesis and that deletions may represent a predominant mecha
nism of p16(INK4A) inactivation. A significant percentage also of LOH was n
oticed at the D9S162 (35%) and D9S126 (38%) loci which lie 6cM and 4cM, res
pectively, far from the area which encodes p16(INK4A), implying that other
tumor suppressor genes (TSGs) may reside in this region. Although the overa
ll incidence of LOH at the examined region was high (58%), we did not obser
ve any correlation with smoking habits, histology and lymph node status. An
other noteworthy finding was the existence of microsatellite instability (M
I) in 11% of the patients. MI provides a marker for replication error pheno
type (RER+), a recently defined manifestation of genetic instability observ
ed in a wide range of tumors. In conclusion, alterations (LOH+MI) at the 9p
21-22 chromosome region are frequent events in NSCLCs and may affect direct
ly or indirectly the expression of p16.